Glenmark Pharmaceuticals gains as IFC plans to invest $75 million in the company

17 Jun 2016 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 775.10, up by 3.70 points or 0.48% from its previous closing of Rs. 771.40 on the BSE.

The scrip opened at Rs. 775.00 and has touched a high and low of Rs. 780.30 and Rs. 773.30 respectively. So far 21,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1261.95 on 21-Aug-2015 and a 52 week low of Rs. 671.50 on 12-Feb-2016.

Last one week high and low of the scrip stood at Rs. 784.90 and Rs. 763.05 respectively. The current market cap of the company is Rs. 21,870.00 crore.

The promoters holding in the company stood at 46.48%, while Institutions and Non-Institutions held 41.92% and 11.60% respectively.

International Finance Corporation (IFC) is planning to invest up to $75 million (around Rs 500 crore) in Glenmark Pharmaceuticals. The pharma major is aiming to raise up to $200 million through market issuance of quasi-equity instruments in order to reduce debt and expand operations, of which IFC proposes to invest up to $75 million.

The proposed investment will allow Glenmark to expand its manufacturing capacity mainly in India, to build research and development capacity for new molecules and to reduce some debt so that internal accruals can be deployed more for R&D.

Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. It manufactures and markets generic formulation products and active pharmaceutical ingredients, both in the domestic and international markets.


Glenmark Pharma Share Price

2000.60 -10.90 (-0.54%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×